Not exact matches
Evidence is more limited and inconsistent regarding the accuracy of the clinical visual
skin examination
for detecting
nonmelanoma skin cancer.
Between 1992 and 2006, the number of treatment procedures
for slow - growing
nonmelanoma skin cancers increased by almost 77 %.
Subjects with treated
nonmelanoma skin cancer, in situ carcinoma or cervical intraepithelial neoplasia, regardless of the disease - free duration, are eligible
for this study if definitive treatment
for the condition has been completed.
«It could be either basal or squamous cell carcinoma, the two
nonmelanoma forms of
skin cancer,» says dermatologist Shawn Allen, MD, spokesperson for the Skin Cancer Foundat
skin cancer,» says dermatologist Shawn Allen, MD, spokesperson for the Skin Cancer Found
cancer,» says dermatologist Shawn Allen, MD, spokesperson
for the
Skin Cancer Foundat
Skin Cancer Found
Cancer Foundation.
Several comments stressed that the USPSTF should place greater emphasis on the benefits of detecting and treating
nonmelanoma skin cancer, noting the risk
for such
cancer to become locally destructive and lead to disfigurement if left untreated.
In addition, risk estimates
for death from
cancer were adjusted
for history of
cancer (other than
nonmelanoma skin cancer) in a first - degree relative (yes vs. no).
Among participants who returned baseline questionnaires, we excluded those who had a history of
cancer (except
nonmelanoma skin cancer), CVD, or diabetes at baseline, left more than 10 items blank on the baseline FFQ in the NHS and more than 70 items blank in the HPFS, or reported implausible energy intake levels (< 500 or > 3500 kcal / d
for women, or < 800 or > 4200 kcal / d
for men).